BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20260317T160000Z
DTEND:20260317T171500Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:North Forge - ElevateIP Webinar
DESCRIPTION:LINK TO REGISTER\n\n \n\nJoin North Forge for a practical look at how to leverage provisional patents\, hosted by North Forge's ElevateIP Program and Ade & Company Inc.\n\n \n\nProvisional Patents as IP Leverage\n\nRisks\, rewards\, and strategic realities\n\n \n\nThis keynote will walk founders through how provisional patent applications actually work in practice\, and where the real risks and benefits lie. The session will cover what level of technical detail is required to properly support a provisional filing\, how enablement affects the strength and future value of an application\, and why "reduction to practice" matters when timing a patent strategy. Attendees will come away with a clearer understanding of when a provisional patent meaningfully strengthens an IP position and when it can create false confidence or long-term problems.\n\n \n\nAbout your keynote speaker:\n\nMichael Williams\, Ph.D. Patent Agent & Biochemist\n\n \n\nMike has a B.Sc. in Genetics (Honours) from the University of Manitoba\, a Ph.D. in Biochemistry and Biophysics from Texas A&M University and was a Postdoctoral Fellow at the National Institute of Health in Bethesda\, Maryland. He has worked as a patent agent at Ade & Company Inc. for 30 years and has extensive experience with patents in many biological areas\, including vaccines\, recombinant proteins and expression systems\, transgenic plants\, antibiotics\, fertilizers\, pesticides and food products.\n\n\n\n \nLINK TO REGISTER
X-ALT-DESC;FMTTYPE=text/html:<p class="fxTZ7 fvFfv lRgAI xFml2" dir="auto" id="viewer-bhbsm415" style="background: transparent\; border: 0px\; margin: 0px\; outline: 0px\; padding: 0px\; vertical-align: baseline\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; text-decoration-line: initial\; text-decoration-color: rgb(0\, 0\, 0)\; text-align: initial\; box-sizing: inherit\;"><br />\n<strong><span style="color: rgb(0\, 120\, 215)\;"><a data-outlook-id="bf19b260-cd5c-479b-83c1-cfd4deefa704" href="https://www.northforge.ca/event-details/provisional-patents-as-ip-leverage"><span style="color: rgb(0\, 120\, 215)\;">LINK TO REGISTER</span></a></span></strong><br />\n&nbsp\;</p>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-v684r1984" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">Join North Forge for a practical look at how to leverage provisional patents\, hosted by North Forge&rsquo\;s </span><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\; font-weight: 700\;">ElevateIP Program</span><span style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">&nbsp\;and </span><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\; font-weight: 700\;">Ade &amp\; Company Inc.</span></span></p>\n\n<div class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-sb5lm2018" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\; margin-inline-start: 0px !important\;">&nbsp\;</div>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-qoze52030" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\; font-weight: 700\;">Provisional Patents as IP Leverage</span></span></p>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-pd6hi2033" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><em style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">Risks\, rewards\, and strategic realities</em></span></p>\n\n<div class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-l5px22003" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\; margin-inline-start: 0px !important\;">&nbsp\;</div>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-yqnhl2008" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">This keynote will walk founders through how provisional patent applications actually work in practice\, and where the real risks and benefits lie. The session will cover what level of technical detail is required to properly support a provisional filing\, how enablement affects the strength and future value of an application\, and why &ldquo\;reduction to practice&rdquo\; matters when timing a patent strategy. Attendees will come away with a clearer understanding of when a provisional patent meaningfully strengthens an IP position and when it can create false confidence or long-term problems.</span></span></p>\n\n<div class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-33e9b1993" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\; margin-inline-start: 0px !important\;">&nbsp\;</div>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-cviyv2050" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><u style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">About your keynote speaker:</span></u></span></p>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-0547m2052" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\; font-weight: 700\;">Michael Williams\, Ph.D. Patent Agent &amp\; Biochemist</span></span></p>\n\n<div class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-3cn1x2054" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\; margin-inline-start: 0px !important\;">&nbsp\;</div>\n\n<p class="DmHO2 wBaGN _8dgGS fi4Jd" dir="auto" id="viewer-4ih0u2055" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; margin: 0px\; color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\; line-height: 1.5\; min-height: auto\; print-color-adjust: exact\; box-sizing: inherit\; white-space-collapse: preserve\;"><span class="fPDec" style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; text-align: initial\; display: block\; box-sizing: inherit\;"><span style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">Mike has a </span><a class="Xx4ZA JOto5" data-hook="web-link" href="http://b.sc/" rel="noopener noreferrer" style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; cursor: pointer\; text-decoration-line: initial\; text-decoration-color: rgb(58\, 37\, 255)\; color: rgb(58\, 37\, 255)\; line-height: 1.5\; min-height: auto\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;" target="_blank"><span style="vertical-align: baseline\; background: 0px 0px\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">B.Sc</span></a><span style="vertical-align: baseline\; background: 0px 0px rgba(0\, 0\, 0\, 0)\; border: 0px\; outline: 0px\; margin: 0px\; padding: 0px\; -webkit-tap-highlight-color: rgba(0\, 0\, 0\, 0)\; box-sizing: inherit\;">. in Genetics (Honours) from the University of Manitoba\, a Ph.D. in Biochemistry and Biophysics from Texas A&amp\;M University and was a Postdoctoral Fellow at the National Institute of Health in Bethesda\, Maryland. He has worked as a patent agent at Ade &amp\; Company Inc. for 30 years and has extensive experience with patents in many biological areas\, including vaccines\, recombinant proteins and expression systems\, transgenic plants\, antibiotics\, fertilizers\, pesticides and food products.</span></span><br />\n<br />\n&nbsp\;</p>\n<strong style="color: rgb(0\, 0\, 0)\; font-family: helvetica-w01-roman\, sans-serif\; font-size: 16px\;"><span style="color: rgb(0\, 120\, 215)\;"><a data-outlook-id="bf19b260-cd5c-479b-83c1-cfd4deefa704" href="https://www.northforge.ca/event-details/provisional-patents-as-ip-leverage"><span style="color: rgb(0\, 120\, 215)\;">LINK TO REGISTER</span></a></span></strong><br />\n<br />\n<br />\n<br />\n&nbsp\;
LOCATION:Virtual
UID:e.9429.1552
SEQUENCE:3
DTSTAMP:20260430T121003Z
URL:https://members.techmanitoba.ca/events/details/north-forge-elevateip-webinar-1552
END:VEVENT

END:VCALENDAR
